Hexosamines, insulin resistance, and the complications of diabetes: current status.

The hexosamine biosynthesis pathway (HBP) is a relatively minor branch of glycolysis. Fructose 6-phosphate is converted to glucosamine 6-phosphate, catalyzed by the first and rate-limiting enzyme glutamine:fructose-6-phosphate amidotransferase (GFAT). The major end product is UDP-N-acetylglucosamine (UDP-GlcNAc). Along with other amino sugars generated by HBP, it provides essential building blocks for glycosyl side chains, of proteins and lipids. UDP-GlcNAc regulates flux through HBP by regulating GFAT activity and is the obligatory substrate of O-GlcNAc transferase. The latter is a cytosolic and nuclear enzyme that catalyzes a reversible, posttranslational protein modification, transferring GlcNAc in O-linkage (O-GlcNAc) to specific serine/threonine residues of proteins. The metabolic effects of increased flux through HBP are thought to be mediated by increasing O-GlcNAcylation. Several investigators proposed that HBP functions as a cellular nutrient sensor and plays a role in the development of insulin resistance and the vascular complications of diabetes. Increased flux through HBP is required and sufficient for some of the metabolic effects of sustained, increased glucose flux, which promotes the complications of diabetes, e.g., diminished expression of sarcoplasmic reticulum Ca(2+)-ATPase in cardiomyocytes and induction of TGF-beta and plasminogen activator inhibitor-1 in vascular smooth muscle cells, mesangial cells, and aortic endothelial cells. The mechanism was consistent with enhanced O-GlcNAcylation of certain transcription factors. The role of HBP in the development of insulin resistance has been controversial. There are numerous papers showing a correlation between increased flux through HBP and insulin resistance; however, the causal relationship has not been established. More recent experiments in mice overexpressing GFAT in muscle and adipose tissue or exclusively in fat cells suggest that the latter develop in vivo insulin resistance via cross talk between fat cells and muscle. Although the relationship between HBP and insulin resistance may be quite complex, it clearly deserves further study in concert with its role in the complications of diabetes.

[1]  Michael Brownlee,et al.  The pathobiology of diabetic complications: a unifying mechanism. , 2005, Diabetes.

[2]  K. Petersen,et al.  Mechanisms of insulin resistance in humans and possible links with inflammation. , 2005, Hypertension.

[3]  D. James,et al.  Akt activation is required at a late stage of insulin-induced GLUT4 translocation to the plasma membrane. , 2005, Molecular endocrinology.

[4]  R. Duggirala,et al.  A single nucleotide polymorphism in MGEA5 encoding O-GlcNAc-selective N-acetyl-beta-D glucosaminidase is associated with type 2 diabetes in Mexican Americans. , 2005, Diabetes.

[5]  F. Schick,et al.  The -913 G/A glutamine:fructose-6-phosphate aminotransferase gene polymorphism is associated with measures of obesity and intramyocellular lipid content in nondiabetic subjects. , 2005, The Journal of clinical endocrinology and metabolism.

[6]  D. James.  MUNC-ing around with insulin action. , 2005, The Journal of clinical investigation.

[7]  A. Paterson,et al.  Characterization of the Histone Acetyltransferase (HAT) Domain of a Bifunctional Protein with Activable O-GlcNAcase and HAT Activities*♦ , 2004, Journal of Biological Chemistry.

[8]  C. Sweep,et al.  Role of hexosamines in insulin resistance and nutrient sensing in human adipose and muscle tissue. , 2004, The Journal of clinical endocrinology and metabolism.

[9]  G. Hart,et al.  O-GlcNAc Transferase Is in a Functional Complex with Protein Phosphatase 1 Catalytic Subunits* , 2004, Journal of Biological Chemistry.

[10]  P. Marchetti,et al.  Activation of the hexosamine pathway leads to phosphorylation of insulin receptor substrate-1 on Ser307 and Ser612 and impairs the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin insulin biosynthetic pathway in RIN pancreatic beta-cells. , 2004, Endocrinology.

[11]  G. Parker,et al.  Hyperglycemia and Inhibition of Glycogen Synthase in Streptozotocin-treated Mice , 2004, Journal of Biological Chemistry.

[12]  B. Witherbee,et al.  Activation of the hexosamine signaling pathway in adipose tissue results in decreased serum adiponectin and skeletal muscle insulin resistance. , 2004, Endocrinology.

[13]  E. Schleicher,et al.  Upstream stimulatory factor (USF) proteins induce human TGF-beta1 gene activation via the glucose-response element-1013/-1002 in mesangial cells: up-regulation of USF activity by the hexosamine biosynthetic pathway. , 2004, The Journal of biological chemistry.

[14]  G. Hart,et al.  The Coactivator of Transcription CREB-binding Protein Interacts Preferentially with the Glycosylated Form of Stat5* , 2004, Journal of Biological Chemistry.

[15]  J. Holloszy,et al.  Glucosamine and glucose induce insulin resistance by different mechanisms in rat skeletal muscle. , 2003, American journal of physiology. Endocrinology and metabolism.

[16]  M. Fukuda,et al.  Diabetes and the Accompanying Hyperglycemia Impairs Cardiomyocyte Calcium Cycling through Increased Nuclear O-GlcNAcylation* , 2003, Journal of Biological Chemistry.

[17]  J. Miyazaki,et al.  The transcription factor PDX-1 is post-translationally modified by O-linked N-acetylglucosamine and this modification is correlated with its DNA binding activity and insulin secretion in min6 beta-cells. , 2003, Archives of biochemistry and biophysics.

[18]  E. Schleicher,et al.  Glutamine:fructose-6-phosphate aminotransferase enzyme activity is necessary for the induction of TGF-β1 and fibronectin expression in mesangial cells , 2003, Diabetologia.

[19]  Nathan Lamarre-Vincent,et al.  Dynamic glycosylation of the transcription factor CREB: a potential role in gene regulation. , 2003, Journal of the American Chemical Society.

[20]  G. Parker,et al.  Insulin Resistance of Glycogen Synthase Mediated byO-Linked N-Acetylglucosamine* , 2003, The Journal of Biological Chemistry.

[21]  H. Hammes,et al.  Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy , 2003, Nature Medicine.

[22]  K. Schey,et al.  High glucose and insulin promote O-GlcNAc modification of proteins, including α-tubulin , 2003 .

[23]  Guoli Chen,et al.  Glucosamine‐induced insulin resistance is coupled to O‐linked glycosylation of Munc18c , 2003, FEBS letters.

[24]  C. Sweep,et al.  Muscle uridine diphosphate-hexosamines do not decrease despite correction of hyperglycemia-induced insulin resistance in type 2 diabetes. , 2002, The Journal of clinical endocrinology and metabolism.

[25]  R. Hresko,et al.  Enhanced O-GlcNAc protein modification is associated with insulin resistance in GLUT1-overexpressing muscles. , 2002, American journal of physiology. Endocrinology and metabolism.

[26]  G. Sesti,et al.  Insulin-Dependent Activation of Endothelial Nitric Oxide Synthase Is Impaired by O-Linked Glycosylation Modification of Signaling Proteins in Human Coronary Endothelial Cells , 2002, Circulation.

[27]  G. Parker,et al.  Altered glycan-dependent signaling induces insulin resistance and hyperleptinemia , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[28]  Xiaoyong Yang,et al.  Recruitment of O-GlcNAc Transferase to Promoters by Corepressor mSin3A Coupling Protein O-GlcNAcylation to Transcriptional Repression , 2002, Cell.

[29]  E. Ravussin.  Cellular sensors of feast and famine. , 2002, The Journal of clinical investigation.

[30]  Zhaohui Feng,et al.  Identification of a biochemical link between energy intake and energy expenditure. , 2002, The Journal of clinical investigation.

[31]  G. Hart,et al.  Dynamic interplay between O-glycosylation and O-phosphorylation of nucleocytoplasmic proteins: alternative glycosylation/phosphorylation of THR-58, a known mutational hot spot of c-Myc in lymphomas, is regulated by mitogens. , 2002, The Journal of biological chemistry.

[32]  G. Hart,et al.  Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[33]  M. Buse,et al.  Defective Akt activation is associated with glucose- but not glucosamine-induced insulin resistance. , 2002, American journal of physiology. Endocrinology and metabolism.

[34]  M. Buse,et al.  Insulin Acutely Regulates Munc18-c Subcellular Trafficking , 2002, The Journal of Biological Chemistry.

[35]  G. Hart,et al.  Dynamic O-Glycosylation of Nuclear and Cytosolic Proteins , 2002, The Journal of Biological Chemistry.

[36]  D. McClain.  Hexosamines as mediators of nutrient sensing and regulation in diabetes. , 2002, Journal of diabetes and its complications.

[37]  M. Brownlee.  Biochemistry and molecular cell biology of diabetic complications , 2001, Nature.

[38]  J. Shaw,et al.  Global and societal implications of the diabetes epidemic , 2001, Nature.

[39]  C. Kahn,et al.  Insulin signalling and the regulation of glucose and lipid metabolism , 2001, Nature.

[40]  G. Hart,et al.  Reciprocity between O-GlcNAc and O-phosphate on the carboxyl terminal domain of RNA polymerase II. , 2001, Biochemistry.

[41]  L. Nolte,et al.  Development of Glucose-induced Insulin Resistance in Muscle Requires Protein Synthesis* , 2001, The Journal of Biological Chemistry.

[42]  Xiaoyong Yang,et al.  O-linkage of N-acetylglucosamine to Sp1 activation domain inhibits its transcriptional capability , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[43]  P. Span,et al.  Short-term glucosamine infusion does not affect insulin sensitivity in humans. , 2001, The Journal of clinical endocrinology and metabolism.

[44]  G. Hart,et al.  Dynamic O-Glycosylation of Nuclear and Cytosolic Proteins , 2001, The Journal of Biological Chemistry.

[45]  Gerald W. Hart,et al.  Glycosylation of Nucleocytoplasmic Proteins: Signal Transduction and O-GlcNAc , 2001, Science.

[46]  A. Saltiel.  New Perspectives into the Molecular Pathogenesis and Treatment of Type 2 Diabetes , 2001, Cell.

[47]  F. N. Lee,et al.  Free fatty acids induce peripheral insulin resistance without increasing muscle hexosamine pathway product levels in rats. , 2001, Diabetes.

[48]  G. Striker.  Glucose toxicity. , 2001, Kidney international.

[49]  I. G. Fantus,et al.  Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[50]  I. G. Fantus,et al.  Overexpression of GFAT activates PAI-1 promoter in mesangial cells. , 2000, American journal of physiology. Renal physiology.

[51]  M. Buse,et al.  High glucose and glucosamine induce insulin resistance via different mechanisms in 3T3-L1 adipocytes. , 2000, Diabetes.

[52]  L. Rossetti.  Perspective: Hexosamines and nutrient sensing. , 2000, Endocrinology.

[53]  E. Bonora,et al.  Effects of glucosamine infusion on insulin secretion and insulin action in humans. , 2000, Diabetes.

[54]  G. Cartee,et al.  Lower calorie intake enhances muscle insulin action and reduces hexosamine levels. , 2000, American journal of physiology. Regulatory, integrative and comparative physiology.

[55]  G. Shulman,et al.  On Diabetes: Insulin Resistance Cellular Mechanisms of Insulin Resistance , 2022 .

[56]  A. Saltiel,et al.  Signaling pathways in insulin action: molecular targets of insulin resistance. , 2000, The Journal of clinical investigation.

[57]  Khan,et al.  Arachidonic acid metabolites alter G protein-mediated signal transduction in heart. Effects on muscarinic K+ channels , 1990, The Journal of general physiology.

[58]  G. Hart,et al.  Regulation of a Cytosolic and Nuclear O-GlcNAc Transferase , 1999, The Journal of Biological Chemistry.

[59]  C. Kahn,et al.  Activation of the hexosamine pathway by glucosamine in vivo induces insulin resistance of early postreceptor insulin signaling events in skeletal muscle. , 1999, Diabetes.

[60]  H. Yki-Järvinen,et al.  Allosteric regulation of glycogen synthase and hexokinase by glucosamine-6-phosphate during glucosamine-induced insulin resistance in skeletal muscle and heart. , 1999, Diabetes.

[61]  N. Ruderman,et al.  Hyperglycemia inhibits insulin activation of Akt/protein kinase B but not phosphatidylinositol 3-kinase in rat skeletal muscle. , 1999, Diabetes.

[62]  M. Buse,et al.  Decreased hexosamine biosynthesis in GH-deficient dwarf rat muscle. Reversal with GH, but not IGF-I, therapy. , 1999, American journal of physiology. Endocrinology and metabolism.

[63]  R. Cooksey,et al.  Printed in U.S.A. Copyright © 1999 by The Endocrine Society Mechanism of Hexosamine-Induced Insulin Resistance in Transgenic Mice Overexpressing Glutamine:Fructose-6- Phosphate Amidotransferase: Decreased Glucose Transporter GLUT4 Translocation and Revers , 2022 .

[64]  H. Heimberg,et al.  Glucosamine-induced Insulin Resistance in 3T3-L1 Adipocytes Is Caused by Depletion of Intracellular ATP* , 1998, The Journal of Biological Chemistry.

[65]  D. Vaughan,et al.  Sp1 Sites Mediate Activation of the Plasminogen Activator Inhibitor-1 Promoter by Glucose in Vascular Smooth Muscle Cells* , 1998, The Journal of Biological Chemistry.

[66]  D. McClain,et al.  Insulin and glucosamine infusions increase O-linked N-acetyl-glucosamine in skeletal muscle proteins in vivo. , 1998, Metabolism: clinical and experimental.

[67]  R. Haltiwanger,et al.  Modulation of O-LinkedN-Acetylglucosamine Levels on Nuclear and Cytoplasmic Proteins in Vivo Using the PeptideO-GlcNAc-β-N-acetylglucosaminidase InhibitorO-(2-Acetamido-2-deoxy-dglucopyranosylidene)amino-N-phenylcarbamate* , 1998, The Journal of Biological Chemistry.

[68]  U. Sauer,et al.  High glucose-induced transforming growth factor beta1 production is mediated by the hexosamine pathway in porcine glomerular mesangial cells. , 1998, The Journal of clinical investigation.

[69]  J. E. Kudlow,et al.  O glycosylation of an Sp1-derived peptide blocks known Sp1 protein interactions , 1997, Molecular and cellular biology.

[70]  M. Buse,et al.  Increased activity of the hexosamine synthesis pathway in muscles of insulin-resistant ob/ob mice. , 1997, The American journal of physiology.

[71]  I. Han,et al.  Reduced O glycosylation of Sp1 is associated with increased proteasome susceptibility , 1997, Molecular and cellular biology.

[72]  Wei Chen,et al.  Role of the glucosamine pathway in fat-induced insulin resistance. , 1997, The Journal of clinical investigation.

[73]  J. Hanover,et al.  O-Linked GlcNAc Transferase Is a Conserved Nucleocytoplasmic Protein Containing Tetratricopeptide Repeats* , 1997, The Journal of Biological Chemistry.

[74]  G. Hart,et al.  Dynamic Glycosylation of Nuclear and Cytosolic Proteins , 1997, The Journal of Biological Chemistry.

[75]  M. Williams,et al.  Development of Insulin Resistance in 3T3-L1 Adipocytes* , 1997, The Journal of Biological Chemistry.

[76]  N. Barzilai,et al.  The Tissue Concentration of UDP-N-acetylglucosamine Modulates the Stimulatory Effect of Insulin on Skeletal Muscle Glucose Uptake* , 1997, The Journal of Biological Chemistry.

[77]  M. Mueckler,et al.  Differential Effects of GLUT1 or GLUT4 Overexpression on Hexosamine Biosynthesis by Muscles of Transgenic Mice* , 1996, The Journal of Biological Chemistry.

[78]  D. McClain,et al.  Overexpression of glutamine:fructose-6-phosphate amidotransferase in transgenic mice leads to insulin resistance. , 1996, The Journal of clinical investigation.

[79]  R. DeFronzo,et al.  Increased Glutamine:Fructose-6-Phosphate Amidotransferase Activity in Skeletal Muscle of Patients With NIDDM , 1996, Diabetes.

[80]  M. Buse,et al.  Effects of Diabetes and Hyperglycemia on the Hexosamine Synthesis Pathway in Rat Muscle and Liver , 1995, Diabetes.

[81]  A. Baron,et al.  Glucosamine induces insulin resistance in vivo by affecting GLUT 4 translocation in skeletal muscle. Implications for glucose toxicity. , 1995, The Journal of clinical investigation.

[82]  Wei Chen,et al.  In vivo glucosamine infusion induces insulin resistance in normoglycemic but not in hyperglycemic conscious rats. , 1995, The Journal of clinical investigation.

[83]  M. Mueckler,et al.  Glucose transport activity in skeletal muscles from transgenic mice overexpressing GLUT1. Increased basal transport is associated with a defective response to diverse stimuli that activate GLUT4. , 1994, The Journal of biological chemistry.

[84]  K. Sharma,et al.  Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-beta. , 1994, The Journal of clinical investigation.

[85]  M. Buse,et al.  Pre-Exposure to Glucosamine Induces Insulin Resistance of Glucose Transport and Glycogen Synthesis in Isolated Rat Skeletal Muscles: Study of Mechanisms in Muscle and in Rat-1 Fibroblasts Overexpressing the Human Insulin Receptor , 1993, Diabetes.

[86]  A. Paterson,et al.  Glucose and glucosamine regulate growth factor gene expression in vascular smooth muscle cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[87]  S. Marshall,et al.  Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system. Role of hexosamine biosynthesis in the induction of insulin resistance. , 1991, The Journal of biological chemistry.

[88]  A. Krolewski,et al.  Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents. , 1990, Annals of internal medicine.

[89]  H. Yki-Järvinen,et al.  Hyperglycemia Decreases Glucose Uptake in Type I Diabetes , 1987, Diabetes.

[90]  S. Steiner.  The Mexican Americans , 1979 .